环境空气污染与临床痴呆:系统综述与荟萃分析
该系统综述与荟萃分析检索EMBASE、PubMed、Web of Science、Psycinfo和OVID Medline至2022年7月,纳入51项成人纵向研究。每2 μg/m³ PM2.5的总体风险比为1.04(95%CI 0.99至1.09);主动病例确认研究为1.42(1.00至2.02),被动病例确认研究为1.03(0.98至1.07)。作者认为PM2.5可能是痴呆的危险因素,二氧化氮和氮氧化物也可能,但数据更有限。
要点
- 每2 μg/m³ PM2.5的痴呆总体风险比为1.04(95%CI 0.99至1.09)。
- 主动病例确认的7项研究中,每2 μg/m³ PM2.5的风险比为1.42(1.00至2.02)。
- 被动病例确认的7项研究中,每2 μg/m³ PM2.5的风险比为1.03(0.98至1.07)。
核心结论
- PM2.5可能是痴呆的危险因素,二氧化氮和氮氧化物也可能,但数据更有限。
- 荟萃分析的风险比受限于需谨慎解读的局限性;研究间结局确认方法不同,每种暴露评估方法可能仅是临床痴呆结局相关因果暴露的替代指标。
- 需要评估关键暴露期和PM2.5以外污染物、并对所有参与者主动评估结局的研究。
- 尽管如此,结果可为疾病负担和监管工作提供当前最佳估计。
研究设计与样本
- 系统综述与荟萃分析,检索EMBASE、PubMed、Web of Science、Psycinfo和OVID Medline自建库至2022年7月。
- 纳入标准为成人(≥18岁)、纵向随访、考虑美国环境保护署标准空气污染物和交通污染替代指标、暴露年均至少一年、报告环境污染物与临床痴呆关联的研究。
- 两名作者独立提取数据并使用非随机暴露研究偏倚风险(ROBINS-E)工具评估偏倚风险。
- 当某污染物至少三项研究采用可比方法时,使用Knapp-Hartung标准误进行荟萃分析。
- 共识别2080条记录,纳入51项研究;多数研究为高偏倚风险,但许多情况下偏倚趋向无效。
主要发现
- 14项研究可对PM2.5进行荟萃分析,每2 μg/m³ PM2.5的总体风险比为1.04(95%CI 0.99至1.09)。
- 使用主动病例确认的7项研究中,每2 μg/m³ PM2.5的风险比为1.42(1.00至2.02)。
- 使用被动病例确认的7项研究中,每2 μg/m³ PM2.5的风险比为1.03(0.98至1.07)。
- 每10 μg/m³二氧化氮的总体风险比为1.02(95%CI 0.98至1.06;9项研究)。
- 每10 μg/m³氮氧化物的总体风险比为1.05(95%CI 0.98至1.13;5项研究);臭氧与痴呆无明确关联(每5 μg/m³风险比1.00,95%CI 0.98至1.05;4项研究)。
关键数值与推荐
- 每2 μg/m³ PM2.5的总体风险比为1.04(95%CI 0.99至1.09)。
- 主动病例确认研究中每2 μg/m³ PM2.5的风险比为1.42(95%CI 1.00至2.02)。
- 被动病例确认研究中每2 μg/m³ PM2.5的风险比为1.03(95%CI 0.98至1.07)。
- 每10 μg/m³二氧化氮的风险比为1.02(95%CI 0.98至1.06)。
- 每10 μg/m³氮氧化物的风险比为1.05(95%CI 0.98至1.13)。
临床怎么用
- 作者认为PM2.5可能是痴呆的危险因素,二氧化氮和氮氧化物也可能,但数据更有限。
- 作者指出荟萃分析的风险比需谨慎解读,结果可为疾病负担和监管工作提供当前最佳估计。
- 原文未据此给出临床推荐。
局限性
- 多数研究为高偏倚风险,但许多情况下偏倚趋向无效。
- 荟萃分析的风险比受限于需谨慎解读的局限性。
- 研究间结局确认方法不同,每种暴露评估方法可能仅是临床痴呆结局相关因果暴露的替代指标。
- 需要评估关键暴露期和PM2.5以外污染物、并对所有参与者主动评估结局的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the role of air pollutants in risk of dementia, considering differences by study factors that could influence findings. DESIGN: Systematic review and meta-analysis. DATA SOURCES: EMBASE, PubMed, Web of Science, Psycinfo, and OVID Medline from database inception through July 2022. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Studies that included adults (≥18 years), a longitudinal follow-up, considered US Environmental Protection Agency criteria air pollutants and proxies of traffic pollution, averaged exposure over a year or more, and reported associations between ambient pollutants and clinical dementia. Two authors independently extracted data using a predefined data extraction form and assessed risk of bias using the Risk of Bias In Non-randomised Studies of Exposures (ROBINS-E) tool. A meta-analysis with Knapp-Hartung standard errors was done when at least three studies for a given pollutant used comparable approaches. RESULTS: 2080 records identified 51 studies for inclusion. Most studies were at high risk of bias, although in many cases bias was towards the null. 14 studies could be meta-analysed for particulate matter <2.5 µm in diameter (PM2.5). The overall hazard ratio per 2 μg/m3 PM2.5 was 1.04 (95% confidence interval 0.99 to 1.09). The hazard ratio among seven studies that used active case ascertainment was 1.42 (1.00 to 2.02) and among seven studies that used passive case ascertainment was 1.03 (0.98 to 1.07). The overall hazard ratio per 10 μg/m3 nitrogen dioxide was 1.02 ((0.98 to 1.06); nine studies) and per 10 μg/m3 nitrogen oxide was 1.05 ((0.98 to 1.13); five studies). Ozone had no clear association with dementia (hazard ratio per 5 μg/m3 was 1.00 (0.98 to 1.05); four studies). CONCLUSION: PM2.5 might be a risk factor for dementia, as well as nitrogen dioxide and nitrogen oxide, although with more limited data. The meta-analysed hazard ratios are subject to limitations that require interpretation with caution. Outcome ascertainment approaches differ across studies and each exposure assessment approach likely is only a proxy for causally relevant exposure in relation to clinical dementia outcomes. Studies that evaluate critical periods of exposure and pollutants other than PM2.5, and studies that actively assess all participants for outcomes are needed. Nonetheless, our results can provide current best estimates for use in burden of disease and regulatory setting efforts. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42021277083.
引用
- Wilker EH, Osman M, Weisskopf MG, et al. Ambient air pollution and clinical dementia: systematic review and meta-analysis. BMJ. 2023. PMID: 37019461. doi:10.1136/bmj-2022-071620
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。